JAMA

Researchers from The University of Osaka have found that rituximab, a monoclonal antibody approved for the treatment of nephrotic syndrome in children in Japan, also improves disease management in adults. The drug kept adults with frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome relapse-free for longer, compared with placebo, with good safety. By reducing the frequency of relapses, rituximab may reduce the reliance on corticosteroids and help to improve quality of life among adult patients with these challenging conditions.

Taiwan's New Public Health Preventive Medicine Strategy Achieves Success After 10 Years

A scientific study of African populations discovers that the beta-amyloid gene is associated with an increased risk of the most common form of glaucoma.

The Faculty of Medicine of The Chinese University of Hong Kong (CUHK) conducted the world’s first study to investigate the association between unrecognised obstructive sleep apnoea (OSA) and postoperative cardiovascular complications. Results showed that patients with unrecognised severe OSA have a two-fold increased risk of postoperative cardiovascular complications compared to those without the disorder. The study has recently been published in the Journal of the American Medical Association (JAMA), suggesting that preoperative OSA screening should be considered in clinical practice to lower the risk of postoperative cardiovascular events.

Faculty of Computer Science and Information Technology (FCSIT), University of Malaya has won 13 Medals at the 2015 Invention, Innovation & Design Exposition (iidex2015) held on April 27 – 30, 2015 at Universiti Teknologi MARA (UiTM) Shah Alam, Malaysia.